Navigation Links
Early Defibrillator After Heart Attack May Not Pay Off

European study finds no survival difference for those with, without device

WEDNESDAY, Oct. 7 (HealthDay News) -- Implanting a defibrillator in the first weeks after a heart attack does not improve survival, a major European study shows.

Fewer deaths from sudden cardiac arrest occurred among those given the devices, which shock the heart into beating again. But, the overall death rate was about the same as for those who did not get defibrillators in the 40 days after a heart attack, the researchers reported.

The study results parallel those of a smaller American trial, said Dr. Gerhard Steinbeck, professor of medicine and chairman of internal medicine at Ludwig-Maximilians University in Munich and lead author of a report in the Oct. 8 issue of the New England Journal of Medicine.

One reason for a second study was that the American trial "might have been a false-negative trial signaled by a relatively small sample size and design flaws," Steinberg said.

But the European study was not done to prove or disprove the earlier trial, which was reported on in 2004, he said. "For many years, these two studies were running parallel," Steinbeck said.

The European trial enrolled 898 of 62,944 people treated for heart attacks. About half had defibrillators implanted, while the other half were given standard treatment, without defibrillators.

In an average follow-up of 37 months, 116 of the defibrillator recipients and 117 of those given standard treatment died. Though there were 27 deaths from sudden cardiac arrest in the defibrillator group, compared with 60 in the standard-treatment group, the overall mortality rate was about the same because of the higher incidence of non-sudden cardiac deaths in the defibrillator group -- 68, versus 39 in the standard-treatment group.

The new results are more firmly based than the earlier findings, Steinbeck said. "We can state that we have included more patients and have done a longer mean [average] follow-up," he said. "Our statistical power is based on [about] 230 deaths, while there were only 120 deaths in the other trial."

Also, the treatment of heart attacks has changed since the earlier trial was done, with artery-opening angioplasty much more common now, Steinbeck said. "In the other trial, 27 percent of patients underwent PCI [percutaneous coronary intervention, the medical term for angioplasty], while in our study it was much higher, more than 70 percent," he said.

The newly reported study results are not at all unexpected, said Dr. Arthur J. Moss, a professor of medicine and cardiology at the University of Rochester in New York and leader of a study reported in 2002 that led to guidelines against early installation of defibrillators after a heart attack.

"We thought they should not be implanted for at least three months, for a variety of reasons," Moss said. "We thought that putting one in early could contribute to heart failure, which is what this study found."

Indeed, analysis of Moss's earlier study had found that longer delays worked best, he said. "We looked at it by quartile, one to 18 months, 18 to 36 months," he said. "The only group that did not benefit got defibrillators in the first 18 months."

The new European study does not rule out later use of defibrillators for people who have had heart attacks, Steinbeck said. Defibrillators can save lives, he said, if implanted when someone develops a sustained abnormal heartbeat, such as ventricular fibrillation.

"If after 48 hours the arrhythmia is sustained, such a patient is a candidate for a defibrillator," Steinbeck said.

More information

The American Heart Association has more on implantable defibrillators.

SOURCES: Gerhard Steinbeck, M.D., professor, medicine, and chairman, Department of Internal Medicine, Ludwig-Maximilians University, Munich, Germany; Arthur J. Moss, M.D., professor, medicine and cardiology, University of Rochester Medical Center, Rochester, N.Y.; Oct. 8, 2009, New England Journal of Medicine

Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Early Drug Treatment May Cut Multiple Sclerosis Risk
2. Early H1N1 Vaccination Saves Lives, Cuts Costs: Study
3. New Government Research Finds One in Every 100 Children Has Autism, of Whom Nearly 40% Are Recovered
4. Molecular imaging holds promise for early intervention in common uterine cancer
5. A potential new imaging agent for early diagnosis of most serious skin cancer
6. Clearly Contacts Director of Web Sales Named as One of Canada's Top Online Marketers of 2009
7. Training clinicians helps reduce rates of early childhood cavities
8. Free Upcoming Program Scheduled to Help Remove Barriers To Early Cervical and Breast Cancer Diagnosis for Local Women
9. Analysis Shows Narrow Age Rating Would Raise Premiums by Nearly 50 Percent, Causing Many Young and Healthy to Forgo Coverage
10. Switching early breast cancer patients to exemestane improves long-term survival
11. LA County Announces: Nearly 40,000 Seniors and Disabled to Lose Home Care Service Hours Due to State Budget Cuts
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... ... convenient way to dispense prescription medications at home, so he invented the patent-pending ... monitor and dispense prescription medications. In doing so, it could help to prevent ...
(Date:11/27/2015)... ... , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% of ... than 3.7 billion people under the age of 50 – or 67% of the population ... global estimates of HSV-1 infection . , "The data shocks us highly!" said Michelle ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... online platform for mental health and wellness consultation, has collaborated with a leading ... bridge the knowledge gap experienced by parents and bring advice from parenting experts ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft ... announces the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite ... LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive ...
(Date:11/26/2015)... ... 2015 , ... The Catalent Applied Drug Delivery Institute today ... dose form selection in early phase drug development. The first of these is ... together the UK’s emerging life sciences companies, corporate partners, and investors, at Milton ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 2015 Research and Markets ( ) has ... Market Outlook to 2019 - Rise in Cardiac Disorders and ... report to their offering. Boston ... scientific and others. --> The ... Boston scientific and others. ...
(Date:11/26/2015)... -- Research and Markets ( ) has ... Horizons and Growth Strategies in the Japanese Therapeutic ... Forecasts, Competitive Intelligence, Emerging Opportunities" report to ... --> This new 247-page report provides ... monitoring market, including emerging tests, technologies, instrumentation, sales ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the Global Cell Surface Testing ... Opportunities" report to their offering.  ... the addition of the  "2016 Future ...
Breaking Medicine Technology: